MarketPeel
Pricing
…
BH

Brad Hively

TOI
CHIEF EXECUTIVE OFFICER · ONCOLOGY INSTITUTE, INC. · CIK 0001891124
FILING MIX · LIFETIME68%/32%
BUYS
34
SELLS
16
TOTAL VALUE
$9.96M
COMPANIES
1
ACTIVE SINCE
Jan 2021
HOLDINGS NOW
411,976
AVG SELL PX
$3.25
TRADE KIND
SHOWING 50 / 50
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
11 backtested trades · 8 horizons · 9 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Brad Hively, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d11+100.00%+0.06%+0.69%-0.63%-10.68%—
14d11+100.00%-4.11%-0.03%-4.08%-14.99%—
30d11+100.00%+25.57%+1.46%+24.11%-18.69%—
60d11+72.73%+103.24%+2.99%+100.25%+12.26%—
90d11+81.82%+79.79%+5.23%+74.56%-5.85%—
180d11+90.91%+339.36%+10.52%+328.84%-22.25%—
1y11(1 pending)+60.00%+380.70%+19.77%+444.47%+92.55%—
2y11(8 pending)+33.33%+3.20%+54.09%-50.89%-23.84%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TOI · 411,976 shares · as of Aug 21, 2026
0644,9101,289,8191,934,7292,579,63820222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 34 buys / 16 sellsCOVERAGE · 23 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TOI
ONCOLOGY INSTITUTE, INC.
SALE10b5-1
10b5-1 plan
298,853$6.51$1.95M411,976Aug 21, 2026Aug 24, 2026 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
27,108——710,829Jul 27, 2026Jul 29, 2026 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
SALE
13,333$3.77$50.3K683,721Dec 15, 2025Dec 16, 2025 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
32,407——697,054Nov 20, 2025Nov 24, 2025 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
41,667——664,647Nov 20, 2025Nov 24, 2025 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
SALE
20,221$4.06$82.1K622,980Aug 19, 2025Aug 21, 2025 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASE
946,460——0Jun 3, 2025Jun 5, 2025 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASE
684,528$0.85$581.8K1,396,561Jun 3, 2025Jun 5, 2025 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASE
946,460$0.85$804.5K2,579,638Jun 3, 2025Jun 5, 2025 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASE
105,320——0Jun 3, 2025Jun 5, 2025 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
SALE
108,532$2.87$311.5K603,501Jun 3, 2025Jun 5, 2025 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASE
131,297$1.87$245.5K1,633,178Jun 3, 2025Jun 5, 2025 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASE
105,320$0.48$50.7K1,501,881Jun 3, 2025Jun 5, 2025 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
SALE
1,867,605$2.87$5.36M712,033Jun 3, 2025Jun 5, 2025 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASE
131,297——0Jun 3, 2025Jun 5, 2025 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASE
684,528——0Jun 3, 2025Jun 5, 2025 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASE
4,528$0.13$5664,528Mar 26, 2025Mar 28, 2025 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASE
9,056$1.04$9.4K675,809Mar 26, 2025Mar 28, 2025 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASE
22,640$0.13$2.8K22,640Mar 26, 2025Apr 28, 2025 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASE
45,280$1.04$47.2K712,033Mar 26, 2025Apr 28, 2025 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASE
50,000$0.15$7.5K666,753Dec 2, 2024Dec 2, 2024 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASE
250,000$0.17$42.5K616,753Nov 26, 2024Dec 2, 2024 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
44,000——720,203Nov 22, 2024Nov 25, 2024 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
SALE
353,450——366,753Nov 12, 2024Dec 2, 2024 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
SALE
18,121$0.46$8.3K676,203Jun 17, 2024Jun 20, 2024 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
SALE
19,526$0.58$11.2K694,324May 22, 2024May 23, 2024 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
42,652——713,850Dec 26, 2023Dec 28, 2023 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
SALE
25,867$2.19$56.7K671,198Nov 21, 2023Nov 22, 2023 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
SALE
25,000——1,745,431Nov 17, 2023Nov 21, 2023 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
SALE
25,000$2.24$56.0K697,065Nov 17, 2023Nov 21, 2023 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASE
25,000$0.85$21.3K722,065Nov 17, 2023Nov 21, 2023 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
SALE
27,117$2.39$64.8K697,065Nov 14, 2023Nov 15, 2023 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASE
47,000$0.85$40.0K771,182Nov 13, 2023Nov 15, 2023 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
SALE
47,000$2.52$118.6K724,182Nov 13, 2023Nov 15, 2023 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
SALE
47,000——1,770,431Nov 13, 2023Nov 15, 2023 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
168,512——724,182Mar 17, 2023Mar 21, 2023 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
421,280——421,280Mar 17, 2023Mar 21, 2023 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
525,188——525,188Nov 17, 2022Nov 21, 2022 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
103,469——555,670Nov 17, 2022Nov 21, 2022 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
SALE
Chief Executive Officer
9,718$2.03$19.7K452,201Nov 15, 2022Nov 17, 2022 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
SALE
Chief Executive Officer
9,718$2.03$19.7K452,201Nov 15, 2022Nov 22, 2022 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
108,469——461,919Mar 21, 2022Mar 23, 2022 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
88,090——88,090Mar 21, 2022Mar 23, 2022 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
550,563——550,563Mar 21, 2022Mar 29, 2022 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
993,460———Nov 12, 2021Nov 16, 2021 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
823,971———Nov 12, 2021Nov 16, 2021 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
212,070——363,450Nov 12, 2021Nov 18, 2021 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
141,380——141,380Nov 12, 2021Nov 18, 2021 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
212,070——212,070Jan 12, 2021Nov 16, 2021 ↗View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
141,380——141,380Jan 12, 2021Nov 16, 2021 ↗View →
Other insiders · TOI
Loading peer insiders…
About this filer
CIK 0001891124
ROLE
Chief Executive Officer
PRIMARY
TOI
COMPANIES
1
ACTIVE SINCE
Jan 2021
MARKETPEEL · /INSIDER/0001891124DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback